Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

ClinicalTrials.gov ID: NCT01472185

Public ClinicalTrials.gov record NCT01472185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 9:42 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Ranolazine Monotherapy in Subjects With Type 2 Diabetes Mellitus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a randomized, double-blind, placebo-controlled, parallel-group, multi-center study to determine the effect of ranolazine when given as monotherapy on glycemic control in subjects with type 2 diabetes mellitus (T2DM) who were inadequately controlled with diet and exercise alone and who are treatment naive to antihyperglycemic therapy or have not received antihyperglycemic therapy in the 90 days (or thiazolidinediones \[TZDs\] for at least 24 weeks) prior to screening, and to characterize the relationship between HbA1c reduction and other glycemic parameters in subjects with T2DM.

Study identification

NCT ID
NCT01472185
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Gilead Sciences
Industry
Enrollment
465 participants

Conditions and interventions

Interventions

Drug · Behavioral

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 2011 (Type not available)
Primary completion
Oct 2013 (Actual)
Completion
Oct 2013 (Actual)
Last update posted
Oct 24, 2014

2011 – 2013

United States locations

U.S. sites
57
U.S. states
22
U.S. cities
52
Facility City State ZIP Site status
Thunderbird Internal Medicine/Clinical Research Advantage Glendale Arizona 85306 —
Central Phoenix Medical Clinic Phoenix Arizona 85020 —
Desert Sun Clinical Research, LLC Tucson Arizona 85710 —
Eclipse Clinical Research Tucson Arizona 85745 —
North Central Arkansas Medical Associates Mountain Home Arkansas 72653 —
Paul W. Davis, MD, Private Practice Pine Bluff Arkansas 71603 —
Southland Clinical Research Center, Inc. Fountain Valley California 92708 —
Global Research Management Glendale California 91205 —
National Research Institute Los Angeles California 90057 —
Spectrum Clinical Research Institute, Inc Moreno Valley California 92553 —
Sacramento Heart and Vascular Medical Associates Sacramento California 95825 —
Clearview Medical Research LLC Santa Clarita California 91350 —
Infosphere Clinical Research West Hills California 91307 —
Boca Raton Clinical Research Associates, Inc Boca Raton Florida 33432 —
PAB Clinical Research Brandon Florida 33511 —
Florida Research Network, LLC Gainesville Florida 32605-4253 —
A G A Clinical Trials Hialeah Florida 33012 —
Jacksonville Center for Clinical Research Jacksonville Florida 32216 —
Baptist Diabetes Associates Miami Florida 33156 —
NextPhase Clinical Trials, Inc. Miami Beach Florida 33140 —
Precision Research Organization Miami Lakes Florida 33016 —
Suncoast Clinical Research New Port Richey Florida 34652 —
Florida Institute for Clinical Research LLC Orlando Florida 32822 —
Regenerate Clinical Trials South Miami Florida 33143 —
Synergy Therapeutic Partners Atlanta Georgia 30127 —
CTL Research Eagle Idaho 83616 —
Cedar-Crosse Research Center Chicago Illinois 60607 —
LaPorte County Institute for Clinical Research Michigan City Indiana 46360 —
Clinical Trials Management, LLC Metairie Louisiana 70006 —
MD Medical Research Oxon Hill Maryland 20745 —
IRC Clinics, Inc Towson Maryland 21204 —
Associated Internal Medicine Specialists, P.C. Battle Creek Michigan 49015 —
Albuquerque Clinical Trials Albuquerque New Mexico 87102 —
University of New Mexico Clinical and Translational Science Center Albuquerque New Mexico 87131 —
Clinical Research Solution New York New York 10016 —
PMG Research of Charlotte Charlotte North Carolina 28202 —
PharmQuest Greensboro North Carolina 27408 —
PMG Research of Salisbury Salisbury North Carolina 28144 —
Clinical Inquest Center, Ltd. Beavercreek Ohio 45431 —
Infinity Research Group, LLC Oklahoma City Oklahoma 73103 —
Blair Medical Associates, Inc, Station Medical Center Altoona Pennsylvania 16602 —
Southeastern Research Associates, Inc. Taylors South Carolina 29687 —
HCCA Clinical Research Solutions Columbia Tennessee 38401 —
HCCA Clinical Research Solution Jackson Tennessee 38305 —
New Phase Research & Development Knoxville Tennessee 37923 —
HCCA Clinical Research Solutions Smyrrna Tennessee 37167 —
The University of Texas Southwestern Medical Center at Dallas Dallas Texas 75390 —
Excel Clinical Research, LLC Houston Texas 77081 —
Texas Center for Drug Development, PA Houston Texas 77081 —
Humble Cardiology Associates Humble Texas 77338 —
Juno Research, LLC Katy Texas 77450 —
Cetero Research San Antonio Texas 78237 —
Discovery Clinical Trials San Antonio Texas 78258 —
Highland Clinical Research Salt Lake City Utah 84124 —
Jean Brown Research Salt Lake City Utah 84124 —
Burke Internal Medicine & Research Burke Virginia 22015 —
Manassas Clinical Research Center Manassas Virginia 20110 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 102 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01472185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2014 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01472185 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →